ORIO Cage System - Polymeric spinal fusion cage, non-sterile

Krajina: Austrália

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Dostupné z:

Emergo Asia Pacific Pty Ltd T/a Emergo Australia

Trieda:

Class IIb

Výrobca:

Spinecraft 777 Oakmont Lane, Westmont, IL, 60559 United States Of America

Terapeutické oblasti:

60762 - Polymeric spinal fusion cage, non-sterile

Terapeutické indikácie:

This system is indicated for use in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine with accompanying radicular symptoms at one disc level. DDD is defined as discogenic pain with degeneration of the disc confirmed by patient history and radiographic studies. This system is used to facilitate intervertebral body fusion in the cervical spine and are placed via an anterior approach at the C3 to C7 disc levels using autograft bone. This system is to be used with supplemental fixation. Patients should have at least six (6) weeks of non-operative treatment prior to treatment with an intervertebral cage. This system is for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the lumbar spine at one or two contiguous levels from L2-S1. Degenerative disc disease is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These DDD patients may have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). This system is to be used with autogenous bone graft and implanted via a transforaminal, open posterior or lateral approach. This system to be used with supplemental fixation. Patients should have at least (6) months of non-operative treatment prior to treatment with an intervertebral cage.

Stav Autorizácia:

A

Dátum Autorizácia:

2020-08-04